找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Breast Cancer Metastasis and Drug Resistance; Progress and Prospec Aamir Ahmad Book 20131st edition Springer Science+Business Media New Yor

[復制鏈接]
樓主: 日月等
31#
發(fā)表于 2025-3-26 22:11:55 | 只看該作者
32#
發(fā)表于 2025-3-27 01:26:40 | 只看該作者
Development of Notch Pathway Inhibitors for Cancer Therapy,ing developed. In this review, we describe the basics of Notch signaling, the role of Notch in normal and cancer stem cells; finally we describe opportunity and challenges in the development of Notch inhibitors as novel targeted agents for cancer patients.
33#
發(fā)表于 2025-3-27 09:16:57 | 只看該作者
Epigenetic Factors in Breast Cancer Progression,processes involved in the initiation and progression of breast carcinogenesis. This chapter describes the major epigenetic modifications involved in breast carcinogenesis and use of various epigenetic modulators in preclinical as well as in clinical trials against breast carcinogenesis.
34#
發(fā)表于 2025-3-27 12:17:09 | 只看該作者
Understanding Tamoxifen Resistance of Breast Cancer Based on Integrative Bioinformatics Approaches,The analyses reveal that the tamoxifen resistant tumors are highly proliferative and display a distinctive expression profile for genes related to inflammation and angiogenesis compared to tamoxifen sensitive tumors. The bioinformatics analysis also identifies a set of small molecules that may reverse the tamoxifen resistance in breast tumor.
35#
發(fā)表于 2025-3-27 15:14:59 | 只看該作者
Utility, Limitations and Lacunae platinum and ruthenium based drugs against breast cancer. Chemical formulae and a brief description of the manifold biological activities of some important such compounds are provided which might be of interest to inorganic chemists, medicinal chemists, biologists, and clinicians alike.
36#
發(fā)表于 2025-3-27 21:49:23 | 只看該作者
Gabriele Gaziev,Enrico Finazzi Agròancer. Furthermore, these molecular signatures could not only help to identify new therapeutic targets, but also allow physicians to design more effective and targeted therapeutic strategies for achieving better treatment outcomes of breast cancer patients.
37#
發(fā)表于 2025-3-27 23:04:03 | 只看該作者
38#
發(fā)表于 2025-3-28 04:57:03 | 只看該作者
39#
發(fā)表于 2025-3-28 08:03:01 | 只看該作者
40#
發(fā)表于 2025-3-28 10:27:49 | 只看該作者
s and some novel signaling pathways?.Excellent source for of?This volume?comprehensively?covers recent prrogress in breast cancer research. In an effort to successfully treat breast cancer, it is imperative to a) fully understand the disease with all its heterogeneity, b) understand the factors that
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-19 02:39
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
定边县| 沾化县| 老河口市| 利川市| 白城市| 庆云县| 钟山县| 广平县| 辉南县| 晋州市| 高淳县| 综艺| 榆中县| 正蓝旗| 光山县| 印江| 林西县| 平舆县| 三亚市| 宁海县| 剑阁县| 南岸区| 民和| 密云县| 六安市| 大悟县| 彭阳县| 登封市| 南川市| 平定县| 鄱阳县| 西平县| 安仁县| 阳江市| 山丹县| 仁布县| 广东省| 绥中县| 林芝县| 牡丹江市| 通许县|